PROTEIN BASED PHARMACEUTICAL USED

Brand	Owner (click to sort)	Address	Description
BENEFIX	GENETICS INSTITUTE	87 Cambridge Park Drive Cambridge MA 02140	protein based pharmaceutical used to promote blood cell growth;
TRUNINE	GENETICS INSTITUTE, INC.	87 CambridgePark Drive Cambridge MA 02140	protein based pharmaceutical used to promote blood cell growth;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

The present invention relates to a novel protein which binds to Osteoclastogenesis Inhibitory Factor (OCIF-binding molecule; OBM), a process for preparing the same, DNA encoding said protein, a protein having an amino acid sequence encoded by this DNA, a method for producing said protein by genetic engineering technique, and a pharmaceutical composition containing said protein. In addition, screening methods for a substance for controlling expression of said protein using said protein and the DNA, a substance which inhibits or protein through binding to said protein, the substance obtained by the screening methods, and a pharmaceutical composition which contains this substance are disclosed. An antibody for said protein, a process for preparing the same, a measuring method of said protein using the antibody, and a medicine comprising the antibody are also disclosed.